ArticleMarine biotechnology (New York, N.Y.)2026
Application and Effects of GDF9 as a Novel Inductive Additive on Early Ovarian Development in Japanese Eel (Anguilla japonica).
Article in Marine biotechnology (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Anguilla japonica (Japanese eel) is a commercially valuable aquaculture species, yet large-scale artificial reproduction remains a major unresolved challenge. This study evaluated the potential of growth differentiation factor 9 (GDF9), an oocyte-derived regulator, as a supplementary additive during hormonally induced ovarian development in Japanese eel. Compared with treatment using gonadotropin analogs alone, co-administration of exogenous recombinant GDF9 significantly enhanced early ovarian development, as indicated by an increased gonadosomatic index (GSI), improved follicular growth, and elevated serum estradiol (E2) and vitellogenin (VTG) levels. Transcriptomic analysis showed that differentially expressed genes (DEGs) were significantly enriched in biological processes and pathways related to EGF signaling, angiogenesis, cell proliferation, transmembrane transport, and reproductive signaling, including the GnRH, FoxO, and Apelin pathways. Metabolomic profiling further revealed significant changes in metabolites associated with carbohydrate metabolism, amino acid biosynthesis and metabolism, and steroid-related pathways. Integrated analysis demonstrated coordinated correlations between key DEGs and differential metabolites, particularly in pathways involved in steroidogenesis, nutrient transport, and amino acid metabolism. These findings suggest that GDF9 may promote early ovarian development through coordinated regulation of gene expression and metabolic activity. As a supplementary molecular additive, GDF9 shows promise for improving hormone-based induction strategies in Japanese eel and may provide useful insights for enhancing artificial reproduction in other teleost species.
Indexed as
Identifiers
42113277What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.